APA

Keymeulen B., Vandemeulebroucke E., Ziegler A. G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., Schandene L., Crenier L., De Block C., Seigneurin J., De Pauw P., Pierard D., Weets I., Rebello P., Bird P., Berrie E., Frewin M., Waldmann H., Bach J., Pipeleers D. & Chatenoud L. (20050628). Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. : The New England journal of medicine.

Chicago

Keymeulen Bart, Vandemeulebroucke Evy, Ziegler Anette G, Mathieu Chantal, Kaufman Leonard, Hale Geoff, Gorus Frans, Goldman Michel, Walter Markus, Candon Sophie, Schandene Liliane, Crenier Laurent, De Block Christophe, Seigneurin Jean-Marie, De Pauw Pieter, Pierard Denis, Weets Ilse, Rebello Peppy, Bird Pru, Berrie Eleanor, Frewin Mark, Waldmann Herman, Bach Jean-François, Pipeleers Daniel and Chatenoud Lucienne. 20050628. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. : The New England journal of medicine.

Harvard

Keymeulen B., Vandemeulebroucke E., Ziegler A. G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., Schandene L., Crenier L., De Block C., Seigneurin J., De Pauw P., Pierard D., Weets I., Rebello P., Bird P., Berrie E., Frewin M., Waldmann H., Bach J., Pipeleers D. and Chatenoud L. (20050628). Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. : The New England journal of medicine.

MLA

Keymeulen Bart, Vandemeulebroucke Evy, Ziegler Anette G, Mathieu Chantal, Kaufman Leonard, Hale Geoff, Gorus Frans, Goldman Michel, Walter Markus, Candon Sophie, Schandene Liliane, Crenier Laurent, De Block Christophe, Seigneurin Jean-Marie, De Pauw Pieter, Pierard Denis, Weets Ilse, Rebello Peppy, Bird Pru, Berrie Eleanor, Frewin Mark, Waldmann Herman, Bach Jean-François, Pipeleers Daniel and Chatenoud Lucienne. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. : The New England journal of medicine. 20050628.